Setting the Benchmark for salmon
Biotech firm Benchmark Holdings, which develops vaccines to keep fish healthy rather than using antibiotics to treat disease, is to start producing salmon eggs at its new land based breeding facility in Norway.
The Sheffield-based firm said the new facility will increase Benchmark’s in-house capacity by 75 per cent. Global demand for salmon has grown by 6-7 per cent a year and is expected to increase substantially over the next decade.
Benchmark said its new Salten facility has been built to the highest standards of technology and biosecurity, and will be the most modern salmon egg production site in the world.
The increased capacity will allow Benchmark to supply the global market with biosecure eggs yearround.